This strategic assessment report, from Markntel Advisors, on Single-use Pumps in the Biopharmaceutical Market provides a comprehensive analysis that reflects today’s market realities and future business possibilities for the forecast period of 2022 to 2027. The report chapters analyze the industry in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the key participants and investors in identifying the low-hanging fruits available and formulating the growth strategies to expedite their growth process.
What is the Size or Growth Rate of the Single-use Pumps in the Biopharmaceutical Market?
The Single-use Pumps in the Biopharmaceutical market is projected to grow at a CAGR of around 6.21% during the forecast period, 2022-2027. The market experienced a flourishing growth during the historical period, owing to increasing biopharma product manufacturing & other advantages associated with the single-use systems, such as flexibility, scalability, etc., in various developed & emerging economies. The majority of biopharmaceutical processes use single-use technologies, including mammalian cell culture, both upstream & downstream.
|Study Period||Historical Data: 2017-20|
|Base Year: 2021|
|Forecast Period: 2022-27|
|Regions Covered||North America: The US, Canada, Mexico|
|South America: Brazil, Argentina, Rest of South America|
|Europe: Germany, The UK, France, Russia Rest of Europe|
|Asia-Pacific: China, India, Japan, South Korea, Rest of Asia-Pacific|
|Middle East & Africa: Saudi Arabia, South Africa, Rest of MEA|
|Key Companies Profiled||PSG Dover, Quantex Arc, Watson Marlow, Colly Flowtech AB, Levitronix, Pumpcell, Fluid Flow, PROMECON GmbH, CerCell, ALMATECHNIK AG, Verder International B.V., ProMinent GmbH, Others|
|Unit Denominations||USD Million/Billion|
What are the Single-use Pumps in the Biopharmaceutical Industry Driving Factors and Major Challenges?
Driving Factor: Increasing Demand for Biopharmaceutical Product Manufacturing
Biopharmaceutical product manufacturing is rapidly growing & becoming increasingly competitive. The success of the clinical pipeline has led to an unprecedented number of new biologic launches & an increase in the share of new approvals from the U.S Food and Drug Administration. In addition to this, there has been significant growth in the research & development of orphan drugs as well. According to the European Medicines Agency statistics, 207 initial orphan marketing authorizations have been granted & 126 active initial authorizations of orphan drugs are to be marketed as of 2022. Therefore, the clinical research, as well as commercial manufacturing of orphan & niche drugs, would witness a substantial increase in the coming years.
Growth Challenges: Limited Number of Gamma Irradiation Facilities
Gamma Irradiation has become the most common irradiation sterilization technology, with approximately 300 irradiation facilities across the globe. The largest application of gamma irradiation is the sterilization of single-use systems & medical devices to ensure a lower risk of infection. Additionally, Cobalt-60 is a radioactive isotope that produces gamma radiation & the amount of Cobalt-60 in an irradiator determines the volume of the product that can be processed. Therefore, the demand for Cobalt-60 continues to grow with the rising adoption of single-use pumps & other technologies.
However, the supply chain of Cobalt-60 is critical in ensuring the global demand for gamma irradiation facilities. Subsequently, the lower production of Cobalt-60 leads to the functioning of a lower number of gamma irradiation facilities, which is considered to restrain the manufacturing of single-use pumps across the globe.
Link to Download Free Sample PDF Of Single-use Pumps in the Biopharmaceutical Market – Download Now It’s Free
Report Table of Content
- Product Definition
- Research Process
- Market Segmentation
- Executive Summary
- Impact of COVID-19 on Global Single Use Pumps in Biopharmaceutical Market
- Global Single Use Pumps in Biopharmaceutical Market Trends & Insights
- Global Single Use Pumps in Biopharmaceutical Market Dynamics
- Growth Drivers
- Impact Analysis
- Global Single Use Pumps in Biopharmaceutical Market Policies, Regulations, Product Standards
- Global Single Use Pumps in Biopharmaceutical Market- Supply Chain Analysis
- Global Single Use Pumps in Biopharmaceutical Patent Analysis
- Global Single Use Pumps in Biopharmaceutical Market Hotspot & Opportunities
- Global Single Use Pumps in Biopharmaceutical Market Outlook, 2017-2027F
The Regional Division of the Industry
Single-use Pumps in the Biopharmaceutical Market is studied based on its regional analysis, divided across Region: –
- North America
- South America
- Middle East & Africa
Of all the regions globally, North America held a considerable market share during the historical period, owing to the growing R&D investments in biopharma product development. The US has contributed significantly to scaling up the R&D related to biologics, drugs, and other therapeutic areas, which has augmented the clinical trials. Hence, the single-use pumps experienced a soaring market demand in the country. In addition to this, the region has received two biological license applications approved by the US FDA in 2017 for the treatment related to retinal dystrophy & Hepatitis B vaccine production. Similarly, in 2018, Vaxelis (vaccine to prevent diphtheria & tetanus) & recombinant Hepatitis B vaccine also got approved by the US FDA.
A Look into The Current Leading Companies in the Market
The Single-use Pumps in the Biopharmaceutical market competitive landscape provides details of all the competitors and market players. Components included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points only relate to the companies focusing on the Single-use Pumps in the Biopharmaceutical market. The major market participants and players operating in the market are: –
- – PSG Dover
- – Quantex Arc
- – Watson Marlow
- – Colly Flowtech AB
- – Levitronix
- – PumpCell
- – Fluid Flow
- – PROMECON GmbH
- – CerCell
- – ALMATECHNIK AG
- – Verder International B.V.
- – ProMinent GmbH
- – Others
For Any Questions or Further Discussion About the Study, Schedule A Call with Our Expertise Here – https://www.marknteladvisors.com/query/talk-to-our-consultant/single-use-pumps-in-biopharmaceutical-market.html
Market Scope Through Segmentation
The Single-use Pumps in the Biopharmaceutical Market is distinctly diversified and meticulous, with segmented articulations and bifurcations. Therefore, this section’s segmentation and bifurcations are elaborated in detail, including the fluctuations, trends, and market strategies to provide the stakeholder with all the necessary information to form an informed and active decision or understanding.
Each segment is further described in the report to provide a precise and comprehensive detailed section of certain factors and intricacies fluctuating the sales and value of different components. This elaborated analysis focuses on providing the stakeholder with the necessary details to accurately understand the factors influencing each bifurcation. The Single-use Pumps in the Biopharmaceutical Market is expanded across the following bifurcations:
- Peristaltic pumps
- Diaphragm pumps
- Rotary lobe pumps
- Piston pumps
- Polypropylene (PP)
- Polyethylene (PE)
- Upstream bioprocessing
- Downstream Bioprocessing
Available Customizations Service For You
Markntel Advisors offer customizations as per your needs and requirement, keeping our focus on factual data collected. Customization could include:
- A further description of the significant regions garnering the highest market share.
- Breaking the area down.
- A detailed analysis of the profiting and influential market players.
Kindly contact our sales team; they will guide you with your queries and requirements. – Connect with Our Sales Team Now
More Study Report –
About MarkNtel Advisors
We are a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Our Contact Details-
Phone – +1 628 895 8081, +91 120 4278433
Follow Us – Twitter, LinkedIn, Facebook, Pinterest
Press Release – www.marknteladvisors.com/press-release